Clover Biopharmaceuticals (HKSE:02197) Days Sales Outstanding : 57.76 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Clover Biopharmaceuticals Days Sales Outstanding?

Clover Biopharmaceuticals's average Accounts Receivable for the six months ended in Dec. 2023 was HK$13.50 Mil. Clover Biopharmaceuticals's Revenue for the six months ended in Dec. 2023 was HK$42.66 Mil. Hence, Clover Biopharmaceuticals's Days Sales Outstanding for the six months ended in Dec. 2023 was 57.76.

The historical rank and industry rank for Clover Biopharmaceuticals's Days Sales Outstanding or its related term are showing as below:

HKSE:02197' s Days Sales Outstanding Range Over the Past 10 Years
Min: 114.77 Med: 224.15 Max: 224.15
Current: 114.77

During the past 5 years, Clover Biopharmaceuticals's highest Days Sales Outstanding was 224.15. The lowest was 114.77. And the median was 224.15.

HKSE:02197's Days Sales Outstanding is ranked worse than
71.17% of 888 companies
in the Biotechnology industry
Industry Median: 72.545 vs HKSE:02197: 114.77

Clover Biopharmaceuticals's Days Sales Outstanding increased from Dec. 2022 (0.00) to Dec. 2023 (57.76).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Clover Biopharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Clover Biopharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clover Biopharmaceuticals Days Sales Outstanding Chart

Clover Biopharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

224.15

Clover Biopharmaceuticals Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial			-	-	-	412.41	57.76

Competitive Comparison of Clover Biopharmaceuticals's Days Sales Outstanding

For the Biotechnology subindustry, Clover Biopharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clover Biopharmaceuticals's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clover Biopharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Clover Biopharmaceuticals's Days Sales Outstanding falls into.

Clover Biopharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Clover Biopharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	26.367)	/	1 )	/	42.936	*	365
=	26.367					/	42.936	*	365
=	224.15

Clover Biopharmaceuticals's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.635	+	26.367)	/	2 )	/	42.655	*	365 / 2
=	13.501					/	42.655	*	365 / 2
=	57.76

Clover Biopharmaceuticals (HKSE:02197) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Clover Biopharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Clover Biopharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Clover Biopharmaceuticals (HKSE:02197) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clover Biopharmaceuticals Ltd (HKSE:02197) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

1598-1601 West Nanjing Road, 49th Floor, Park Place, Jing’an District, Shanghai, CHN

Website

https://www.cloverbiopharma.com

Clover Biopharmaceuticals Ltd is a clinical-stage biotechnology company committed to developing novel vaccines and biologic therapeutic candidates for infectious diseases as well as cancer and autoimmune diseases.

Executives

Liang Peng	2101 Beneficial owner
Liang Joshua G	2501 Other
Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Hillhouse Investment Management, Ltd.	2102 Investment manager
Aut-xxi Investment Holdings Limited	2201 Interest of corporation controlled by you
Jnry V Holdings Limited	2101 Beneficial owner
Aut-xxi Hk Holdings Limited	2101 Beneficial owner
Aut-xxi Holdings Limited	2201 Interest of corporation controlled by you
Hh Imv Holdings, L.p.	2201 Interest of corporation controlled by you
Hillhouse Fund Iv, L.p.	2201 Interest of corporation controlled by you
Temasek Holdings (private) Limited	2201 Interest of corporation controlled by you
The Core Trust Company Limited	2301 Trustee
Tct (bvi) Limited	2501 Other
Super Novel International Limited	2306 Nominee for another person
Shang Hai Tian He Sheng Tai Qi Ye Guan Li He Huo Qi Ye You Xian He Huo

Clover Biopharmaceuticals (HKSE:02197) Headlines

No Headlines